Shareholders controlling at least 5% of the vote at the General Meeting of Ryvu Therapeutics S.A. convened on July, 13 2020
Read More
Resolutions adopted by the General Meeting of Ryvu Therapeutics S.A.
Read More
Ryvu Therapeutics Strategy for 2020-2022
Read More
Ryvu Therapeutics S.A. Q1 2020 Financial Report
Read More
Ryvu Therapeutics S.A. Annual Report (Summary) 2019
Read More
